[{"Assets_0_Q2_USD":365129000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-32889000.0,"NetIncomeLoss_2_Q2_USD":-36241000.0,"NetIncomeLoss_1_Q2_USD":-20259000.0,"PaymentsOfDividendsCommonStock_2_Q2_USD":0.0,"StockholdersEquity_0_Q2_USD":341799000.0,"Ticker":"KNSA","CIK":"1730430","name":"KINIKSA PHARMACEUTICALS, LTD.","OfficialName":"Kiniksa Pharmaceuticals Ltd. Class A Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"764985918.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180806"}]